High-Level mRNA of Excision Repair Cross-Complementation Group 1 Gene Is Associated With Poor Outcome of Platinum-Based Doublet Chemotherapy of Advanced Nonsmall Cell Lung Cancer Patients

Author： Ren Shengxiang   Zhou Songwen   Zhang Ling   Xu Jianfang   Lv Meijun   Zhang Jie   Zhou Caicun   Zhang Jie  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.28, Iss.10, 2010-11, pp. : 1078-1083

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based treatment for non-small cell lung cancer

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-02 ,pp. : 809-817

Spandidos Publications

Access to resources Recommend Favorite

The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

By Bonanno L.   Costa C.   Majem M.   Favaretto A.   Rugge M.   Rosell R.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1130-1132

Oxford University Press

Access to resources Recommend Favorite

Association between epidermal growth factor receptor mutations and the expression of excision repair cross-complementing protein 1 and ribonucleotide reductase subunit M1 mRNA in patients with non-small cell lung cancer

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 880-884

Spandidos Publications

Access to resources Recommend Favorite

Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy

By                      

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 723-730

Spandidos Publications

Access to resources Recommend Favorite

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis

By Wei Shu-zhen  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 315-321

Humana Press, Inc

Access to resources Recommend Favorite